CCR2 and neoplasm: Collectively, EVs originated from M1-polarized cells represented as a promising platform to specifically transfer the therapeutic cargo to tumor tissue; however, it was still unclear which subtype of EVs was associated with the CCR2-dominated tumor selectivity.